Establishment Labs (ESTA) Stock Forecast, Price Target & Predictions
ESTA Stock Forecast
Establishment Labs stock forecast is as follows: an average price target of $78.00 (represents a 71.73% upside from ESTA’s last price of $45.42) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ESTA Price Target
ESTA Analyst Ratings
Establishment Labs Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 22, 2024 | Joanne Wuensch | Citigroup | $45.00 | $44.05 | 2.16% | -0.92% |
Jun 06, 2024 | Anthony Petrone | Mizuho Securities | $70.00 | $53.89 | 29.89% | 54.12% |
Apr 01, 2024 | Anthony Petrone | Mizuho Securities | $65.00 | $50.90 | 27.70% | 43.11% |
Dec 28, 2022 | - | Stephens | $87.00 | $60.45 | 43.92% | 91.55% |
Apr 22, 2022 | - | BTIG | $110.00 | $81.89 | 34.33% | 142.18% |
Establishment Labs Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $45.00 | $60.00 |
Last Closing Price | $45.42 | $45.42 | $45.42 |
Upside/Downside | -100.00% | -0.92% | 32.10% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 14, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 01, 2024 | Stephens | Neutral | Neutral | Hold |
Oct 01, 2024 | Citigroup | Underperform | Underperform | Hold |
Aug 22, 2024 | Citigroup | Underperform | Underperform | Hold |
Aug 22, 2024 | Stephens | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Neutral | Neutral | Hold |
Jul 10, 2024 | Citigroup | Neutral | Neutral | Hold |
May 22, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 22, 2024 | Citigroup | Buy | Neutral | Downgrade |
Apr 15, 2024 | BTIG | Buy | Buy | Hold |
Establishment Labs Financial Forecast
Establishment Labs Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $31.56M | $38.51M | $48.56M | $46.52M | $43.81M | $38.24M | $41.19M | $38.45M | $35.31M | $29.04M | $31.99M | $30.34M | $26.96M | $22.76M | $10.47M | $24.48M | $24.25M | $22.85M |
Avg Forecast | $90.85M | $76.58M | $79.00M | $69.69M | $68.29M | $58.46M | $56.91M | $49.82M | $52.34M | $40.45M | $43.10M | $35.61M | $31.44M | $40.48M | $47.36M | $45.45M | $43.26M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
High Forecast | $90.85M | $76.58M | $79.00M | $69.69M | $68.29M | $58.46M | $56.91M | $49.82M | $52.34M | $40.85M | $43.10M | $35.61M | $31.62M | $40.48M | $47.36M | $45.45M | $43.26M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
Low Forecast | $90.85M | $76.58M | $79.00M | $69.69M | $68.29M | $58.46M | $56.91M | $49.82M | $52.34M | $40.05M | $43.10M | $35.61M | $31.21M | $40.48M | $47.36M | $45.45M | $43.26M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.95% | 1.03% | 1.02% | 1.01% | 1.02% | 1.07% | 1.09% | 1.01% | 1.04% | 1.07% | 1.20% | 1.07% | 1.16% | 0.84% | 1.05% | 1.09% | 1.18% |
Establishment Labs EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-22.11M | $-21.04M | $-12.20M | $-7.36M | $-10.54M | $-14.13M | $-15.23M | $-2.85M | $-31.43M | $-11.27M | $-1.63M | $-3.58M | $-2.73M | $-307.00K | $-7.35M | $-14.55M | $-2.10M | $-9.87M |
Avg Forecast | $-29.00M | $-24.45M | $-25.22M | $-22.25M | $-21.80M | $-18.66M | $-18.17M | $-15.90M | $-16.71M | $-12.91M | $-13.76M | $-11.37M | $-10.04M | $-12.92M | $-15.12M | $-14.51M | $-13.81M | $-11.92M | $-12.26M | $-3.00M | $-11.13M | $-8.93M | $-9.51M | $-4.11M | $-8.07M | $-6.28M | $-3.99M | $-8.78M | $-7.09M | $-6.20M |
High Forecast | $-29.00M | $-24.45M | $-25.22M | $-22.25M | $-21.80M | $-18.66M | $-18.17M | $-15.90M | $-16.71M | $-12.79M | $-13.76M | $-11.37M | $-9.96M | $-12.92M | $-15.12M | $-14.51M | $-13.81M | $-11.92M | $-12.26M | $-2.40M | $-11.13M | $-8.93M | $-9.51M | $-3.28M | $-8.07M | $-6.28M | $-3.99M | $-7.02M | $-7.09M | $-6.20M |
Low Forecast | $-29.00M | $-24.45M | $-25.22M | $-22.25M | $-21.80M | $-18.66M | $-18.17M | $-15.90M | $-16.71M | $-13.04M | $-13.76M | $-11.37M | $-10.10M | $-12.92M | $-15.12M | $-14.51M | $-13.81M | $-11.92M | $-12.26M | $-3.60M | $-11.13M | $-8.93M | $-9.51M | $-4.93M | $-8.07M | $-6.28M | $-3.99M | $-10.53M | $-7.09M | $-6.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.20% | 1.63% | 0.81% | 0.51% | 0.76% | 1.19% | 1.24% | 0.95% | 2.82% | 1.26% | 0.17% | 0.87% | 0.34% | 0.05% | 1.84% | 1.66% | 0.30% | 1.59% |
Establishment Labs Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-20.54M | $-29.27M | $-16.75M | $-11.94M | $-13.56M | $-18.61M | $-37.11M | $-5.93M | $-11.34M | $-14.68M | $-5.32M | $-6.95M | $-5.64M | $-4.25M | $-10.47M | $-17.76M | $-5.56M | $-12.78M |
Avg Forecast | $873.45K | $-7.56M | $-5.90M | $-10.91M | $-8.37M | $-13.95M | $-10.82M | $-14.74M | $-13.79M | $-17.16M | $-14.32M | $-18.64M | $-25.45M | $-22.37M | $-19.97M | $-18.97M | $-18.93M | $-15.90M | $-11.12M | $-8.12M | $-9.27M | $-10.17M | $-7.83M | $-7.97M | $-5.27M | $-9.59M | $-12.65M | $-10.71M | $-16.33M | $-14.09M |
High Forecast | $873.45K | $-7.56M | $-5.90M | $-10.91M | $-8.37M | $-13.95M | $-10.82M | $-14.74M | $-13.79M | $-13.22M | $-14.32M | $-18.64M | $-24.11M | $-22.37M | $-19.97M | $-18.97M | $-18.93M | $-15.90M | $-11.12M | $-6.50M | $-9.27M | $-10.17M | $-7.83M | $-6.38M | $-5.27M | $-9.59M | $-12.65M | $-8.57M | $-16.33M | $-14.09M |
Low Forecast | $873.45K | $-7.56M | $-5.90M | $-10.91M | $-8.37M | $-13.95M | $-10.82M | $-14.74M | $-13.79M | $-20.26M | $-14.32M | $-18.64M | $-27.59M | $-22.37M | $-19.97M | $-18.97M | $-18.93M | $-15.90M | $-11.12M | $-9.74M | $-9.27M | $-10.17M | $-7.83M | $-9.56M | $-5.27M | $-9.59M | $-12.65M | $-12.86M | $-16.33M | $-14.09M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.81% | 1.31% | 0.84% | 0.63% | 0.72% | 1.17% | 3.34% | 0.73% | 1.22% | 1.44% | 0.68% | 0.87% | 1.07% | 0.44% | 0.83% | 1.66% | 0.34% | 0.91% |
Establishment Labs SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $36.88M | $39.96M | $37.03M | $31.71M | $34.85M | $31.27M | $32.96M | $26.91M | $27.56M | $24.78M | $21.75M | $18.14M | $18.20M | $15.01M | $14.44M | $18.98M | $17.13M | $19.23M |
Avg Forecast | $72.06M | $60.75M | $62.66M | $55.28M | $54.17M | $46.37M | $45.14M | $39.52M | $41.52M | $32.08M | $34.19M | $28.25M | $24.94M | $32.11M | $37.57M | $36.05M | $34.31M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $20.81M | $20.04M | $15.60M | $9.91M | $11.45M | $17.62M | $15.41M |
High Forecast | $72.06M | $60.75M | $62.66M | $55.28M | $54.17M | $46.37M | $45.14M | $39.52M | $41.52M | $32.40M | $34.19M | $28.25M | $25.08M | $32.11M | $37.57M | $36.05M | $34.31M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $24.97M | $20.04M | $15.60M | $9.91M | $13.74M | $17.62M | $15.41M |
Low Forecast | $72.06M | $60.75M | $62.66M | $55.28M | $54.17M | $46.37M | $45.14M | $39.52M | $41.52M | $31.77M | $34.19M | $28.25M | $24.75M | $32.11M | $37.57M | $36.05M | $34.31M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $16.64M | $20.04M | $15.60M | $9.91M | $9.16M | $17.62M | $15.41M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.48% | 1.24% | 0.99% | 0.88% | 1.02% | 1.06% | 1.08% | 0.96% | 1.00% | 1.12% | 0.92% | 0.87% | 0.91% | 0.96% | 1.46% | 1.66% | 0.97% | 1.25% |
Establishment Labs EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.79 | $-1.12 | $-0.65 | $-0.48 | $-0.55 | $-0.76 | $-1.52 | $-0.24 | $-0.47 | $-0.61 | $-0.22 | $-0.29 | $-0.24 | $-0.18 | $-0.45 | $-0.79 | $-0.27 | $-0.62 |
Avg Forecast | $0.03 | $-0.27 | $-0.21 | $-0.39 | $-0.30 | $-0.50 | $-0.39 | $-0.53 | $-0.49 | $-0.61 | $-0.51 | $-0.67 | $-0.91 | $-0.80 | $-0.72 | $-0.68 | $-0.68 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
High Forecast | $0.03 | $-0.27 | $-0.21 | $-0.39 | $-0.30 | $-0.50 | $-0.39 | $-0.53 | $-0.49 | $-0.47 | $-0.51 | $-0.67 | $-0.86 | $-0.80 | $-0.72 | $-0.68 | $-0.68 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
Low Forecast | $0.03 | $-0.27 | $-0.21 | $-0.39 | $-0.30 | $-0.50 | $-0.39 | $-0.53 | $-0.49 | $-0.73 | $-0.51 | $-0.67 | $-0.99 | $-0.80 | $-0.72 | $-0.68 | $-0.68 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.87% | 1.40% | 0.91% | 0.71% | 0.81% | 1.33% | 3.81% | 0.63% | 1.41% | 1.67% | 0.78% | 0.85% | 1.27% | 0.52% | 0.99% | 2.51% | 0.46% | 1.23% |
Establishment Labs Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
APYX | Apyx Medical | $1.19 | $8.50 | 614.29% | Buy |
INGN | Inogen | $8.69 | $26.00 | 199.19% | Buy |
NPCE | NeuroPace | $6.29 | $12.88 | 104.77% | Buy |
FNA | Paragon 28 | $5.62 | $11.50 | 104.63% | Buy |
SGHT | Sight Sciences | $5.21 | $10.25 | 96.74% | Hold |
LUNG | Pulmonx | $6.27 | $11.93 | 90.27% | Buy |
ESTA | Establishment Labs | $45.42 | $78.00 | 71.73% | Buy |
KIDS | OrthoPediatrics | $27.36 | $39.60 | 44.74% | Buy |
LIVN | LivaNova | $51.13 | $70.50 | 37.88% | Buy |
CNMD | CONMED | $70.40 | $96.00 | 36.36% | Buy |
ITGR | Integer | $126.45 | $138.00 | 9.13% | Buy |
SRDX | Surmodics | $37.63 | $39.50 | 4.97% | Buy |
GKOS | Glaukos | $131.77 | $119.33 | -9.44% | Buy |
ESTA Forecast FAQ
Is Establishment Labs a good buy?
Yes, according to 4 Wall Street analysts, Establishment Labs (ESTA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of ESTA's total ratings.
What is ESTA's price target?
Establishment Labs (ESTA) average price target is $78 with a range of $45 to $110, implying a 71.73% from its last price of $45.42. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Establishment Labs stock go up soon?
According to Wall Street analysts' prediction for ESTA stock, the company can go up by 71.73% (from the last price of $45.42 to the average price target of $78), up by 142.18% based on the highest stock price target, and down by -0.92% based on the lowest stock price target.
Can Establishment Labs stock reach $70?
ESTA's average twelve months analyst stock price target of $78 supports the claim that Establishment Labs can reach $70 in the near future.
What are Establishment Labs's analysts' financial forecasts?
Establishment Labs's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $233.48M (high $233.48M, low $233.48M), average EBITDA is $-74.54M (high $-74.54M, low $-74.54M), average net income is $-47.89M (high $-47.89M, low $-47.89M), average SG&A $185.2M (high $185.2M, low $185.2M), and average EPS is $-1.716 (high $-1.716, low $-1.716). ESTA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $316.12M (high $316.12M, low $316.12M), average EBITDA is $-101M (high $-101M, low $-101M), average net income is $-23.497M (high $-23.497M, low $-23.497M), average SG&A $250.75M (high $250.75M, low $250.75M), and average EPS is $-0.842 (high $-0.842, low $-0.842).
Did the ESTA's actual financial results beat the analysts' financial forecasts?
Based on Establishment Labs's last annual report (Dec 2023), the company's revenue was $165.15M, beating the average analysts forecast of $164.74M by 0.25%. Apple's EBITDA was $-60.86M, beating the average prediction of $-52.594M by 15.72%. The company's net income was $-78.502M, missing the average estimation of $-86.765M by -9.52%. Apple's SG&A was $145.58M, beating the average forecast of $130.67M by 11.41%. Lastly, the company's EPS was $-3.07, missing the average prediction of $-3.109 by -1.26%. In terms of the last quarterly report (Dec 2023), Establishment Labs's revenue was $31.56M, beating the average analysts' forecast of $31.44M by 0.37%. The company's EBITDA was $-22.115M, beating the average prediction of $-10.039M by 120.29%. Establishment Labs's net income was $-20.542M, missing the average estimation of $-25.451M by -19.29%. The company's SG&A was $36.88M, beating the average forecast of $24.94M by 47.86%. Lastly, the company's EPS was $-0.79, missing the average prediction of $-0.912 by -13.38%